Every day, around 700 Virbac employees all over the world put all their energy into optimizing today's products and, above all, into creating tomorrow's products. Virbac's innovation is organized to facilitate the development of projects with a global vocation from the outset.
Our Virbac R&D centers are located on five continents. This extensive presence means that we are not only close to production centers, but also as close as possible to the needs of veterinarians, farmers and owners, particularly in the livestock sector where regional specificities (pathologies, farming methods, regulations, etc.) are more pronounced. These sites have multidisciplinary teams and state-of-the-art technical facilities (analytical, formulation) dedicated to the studies needed to develop new products that meet the quality, safety and efficacy requirements demanded by the regulatory authorities and, above all, by our customers.
Finally, in several countries we have units dedicated to the national or regional registration of new products developed in our R&D centers and to the monitoring of regulatory compliance of registration dossiers following changes to the product (manufacturing process and site, improvement in the quality of active ingredients, etc.) or changes to current best practice.
- Biological and pharmaceutical projects for companion and farm animals, non pharma-regulated products for companion animal.
- Development of projects for the entire world, particularly in support of the United States and in collaboration with Vietnam, Brazil, Mexico, China and Japan for companion animal.
- Development of worldwide petfood projects.
- Biological and pharmaceutical projects mainly for ruminants (specialized in bovine & ovine).
- Development of local projects and collaboration in joint projects with Latin America and South Africa.
- Pharmaceutical products projects for companion and farm animals.
- Development of projects for Latin America, Asia and South Africa.
- Pharmaceutical products projects for companion and farm animals, and non pharma-regulated products for companion animals.
- Development of local projects and projects for Europe, in collaboration with France and Vietnam.
- Pharmaceuticals and probiotics projects for farm animals (swine, aquaculture) and companion animals, and non pharma-regulated products for companion animal for Europe and the United States.
- Development of projects for continental Asia, Europe and the United States in support of France.
- Biological projects for farm animals (swine, aquaculture).
- Development of projects for Asia and Latin America, and Europe in collaboration with France.
- Biological and pharmaceutical projects for all animal species, especially aquaculture.
- Development of projects for Latin America.
- Biological projects for ruminants.
- Development of projects for Latin America.
- Development of pharmaceutical and non-pharmaceutical products.
- Development of projects for China in cooperation with France.
- Biological projects for poultry.
- Development of projects for India and Africa.
- Development of pharmaceutical products for all major species (Tokyo).
- Development of biological products for farm animals (Kyoto).
- Development of projects for Asia.